Allergy Immunotherapies Industry Research Report 2024
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
According to APO Research, The global Allergy Immunotherapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapies.
The Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Allergy Immunotherapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
According to APO Research, The global Allergy Immunotherapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapies.
The Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- ALK
- Stallergenes
- HAL
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
- Allergic Rhinitis
- Allergic Asthma
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Allergy Immunotherapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Allergy Immunotherapies by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Subcutaneous Immunotherapy
2.2.3 Sublingual Immunotherapy
2.3 Allergy Immunotherapies by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Allergic Rhinitis
2.3.3 Allergic Asthma
2.3.4 Other
2.4 Assumptions and Limitations
3 ALLERGY IMMUNOTHERAPIES BREAKDOWN DATA BY TYPE
3.1 Global Allergy Immunotherapies Historic Market Size by Type (2019-2024)
3.2 Global Allergy Immunotherapies Forecasted Market Size by Type (2025-2030)
4 ALLERGY IMMUNOTHERAPIES BREAKDOWN DATA BY APPLICATION
4.1 Global Allergy Immunotherapies Historic Market Size by Application (2019-2024)
4.2 Global Allergy Immunotherapies Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Allergy Immunotherapies Market Perspective (2019-2030)
5.2 Global Allergy Immunotherapies Growth Trends by Region
5.2.1 Global Allergy Immunotherapies Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Allergy Immunotherapies Historic Market Size by Region (2019-2024)
5.2.3 Allergy Immunotherapies Forecasted Market Size by Region (2025-2030)
5.3 Allergy Immunotherapies Market Dynamics
5.3.1 Allergy Immunotherapies Industry Trends
5.3.2 Allergy Immunotherapies Market Drivers
5.3.3 Allergy Immunotherapies Market Challenges
5.3.4 Allergy Immunotherapies Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Allergy Immunotherapies Players by Revenue
6.1.1 Global Top Allergy Immunotherapies Players by Revenue (2019-2024)
6.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2019-2024)
6.2 Global Allergy Immunotherapies Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Allergy Immunotherapies Head office and Area Served
6.4 Global Allergy Immunotherapies Players, Product Type & Application
6.5 Global Allergy Immunotherapies Players, Date of Enter into This Industry
6.6 Global Allergy Immunotherapies Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Allergy Immunotherapies Market Size (2019-2030)
7.2 North America Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Allergy Immunotherapies Market Size by Country (2019-2024)
7.4 North America Allergy Immunotherapies Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Allergy Immunotherapies Market Size (2019-2030)
8.2 Europe Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Allergy Immunotherapies Market Size by Country (2019-2024)
8.4 Europe Allergy Immunotherapies Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Allergy Immunotherapies Market Size (2019-2030)
9.2 Asia-Pacific Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Allergy Immunotherapies Market Size by Country (2019-2024)
9.4 Asia-Pacific Allergy Immunotherapies Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Allergy Immunotherapies Market Size (2019-2030)
10.2 Latin America Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Allergy Immunotherapies Market Size by Country (2019-2024)
10.4 Latin America Allergy Immunotherapies Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Allergy Immunotherapies Market Size (2019-2030)
11.2 Middle East & Africa Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Allergy Immunotherapies Market Size by Country (2019-2024)
11.4 Middle East & Africa Allergy Immunotherapies Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 ALK
12.1.1 ALK Company Information
12.1.2 ALK Business Overview
12.1.3 ALK Revenue in Allergy Immunotherapies Business (2019-2024)
12.1.4 ALK Allergy Immunotherapies Product Portfolio
12.1.5 ALK Recent Developments
12.2 Stallergenes
12.2.1 Stallergenes Company Information
12.2.2 Stallergenes Business Overview
12.2.3 Stallergenes Revenue in Allergy Immunotherapies Business (2019-2024)
12.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
12.2.5 Stallergenes Recent Developments
12.3 HAL
12.3.1 HAL Company Information
12.3.2 HAL Business Overview
12.3.3 HAL Revenue in Allergy Immunotherapies Business (2019-2024)
12.3.4 HAL Allergy Immunotherapies Product Portfolio
12.3.5 HAL Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Allergy Immunotherapies by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Subcutaneous Immunotherapy
2.2.3 Sublingual Immunotherapy
2.3 Allergy Immunotherapies by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Allergic Rhinitis
2.3.3 Allergic Asthma
2.3.4 Other
2.4 Assumptions and Limitations
3 ALLERGY IMMUNOTHERAPIES BREAKDOWN DATA BY TYPE
3.1 Global Allergy Immunotherapies Historic Market Size by Type (2019-2024)
3.2 Global Allergy Immunotherapies Forecasted Market Size by Type (2025-2030)
4 ALLERGY IMMUNOTHERAPIES BREAKDOWN DATA BY APPLICATION
4.1 Global Allergy Immunotherapies Historic Market Size by Application (2019-2024)
4.2 Global Allergy Immunotherapies Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Allergy Immunotherapies Market Perspective (2019-2030)
5.2 Global Allergy Immunotherapies Growth Trends by Region
5.2.1 Global Allergy Immunotherapies Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Allergy Immunotherapies Historic Market Size by Region (2019-2024)
5.2.3 Allergy Immunotherapies Forecasted Market Size by Region (2025-2030)
5.3 Allergy Immunotherapies Market Dynamics
5.3.1 Allergy Immunotherapies Industry Trends
5.3.2 Allergy Immunotherapies Market Drivers
5.3.3 Allergy Immunotherapies Market Challenges
5.3.4 Allergy Immunotherapies Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Allergy Immunotherapies Players by Revenue
6.1.1 Global Top Allergy Immunotherapies Players by Revenue (2019-2024)
6.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2019-2024)
6.2 Global Allergy Immunotherapies Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Allergy Immunotherapies Head office and Area Served
6.4 Global Allergy Immunotherapies Players, Product Type & Application
6.5 Global Allergy Immunotherapies Players, Date of Enter into This Industry
6.6 Global Allergy Immunotherapies Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Allergy Immunotherapies Market Size (2019-2030)
7.2 North America Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Allergy Immunotherapies Market Size by Country (2019-2024)
7.4 North America Allergy Immunotherapies Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Allergy Immunotherapies Market Size (2019-2030)
8.2 Europe Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Allergy Immunotherapies Market Size by Country (2019-2024)
8.4 Europe Allergy Immunotherapies Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Allergy Immunotherapies Market Size (2019-2030)
9.2 Asia-Pacific Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Allergy Immunotherapies Market Size by Country (2019-2024)
9.4 Asia-Pacific Allergy Immunotherapies Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Allergy Immunotherapies Market Size (2019-2030)
10.2 Latin America Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Allergy Immunotherapies Market Size by Country (2019-2024)
10.4 Latin America Allergy Immunotherapies Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Allergy Immunotherapies Market Size (2019-2030)
11.2 Middle East & Africa Allergy Immunotherapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Allergy Immunotherapies Market Size by Country (2019-2024)
11.4 Middle East & Africa Allergy Immunotherapies Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 ALK
12.1.1 ALK Company Information
12.1.2 ALK Business Overview
12.1.3 ALK Revenue in Allergy Immunotherapies Business (2019-2024)
12.1.4 ALK Allergy Immunotherapies Product Portfolio
12.1.5 ALK Recent Developments
12.2 Stallergenes
12.2.1 Stallergenes Company Information
12.2.2 Stallergenes Business Overview
12.2.3 Stallergenes Revenue in Allergy Immunotherapies Business (2019-2024)
12.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
12.2.5 Stallergenes Recent Developments
12.3 HAL
12.3.1 HAL Company Information
12.3.2 HAL Business Overview
12.3.3 HAL Revenue in Allergy Immunotherapies Business (2019-2024)
12.3.4 HAL Allergy Immunotherapies Product Portfolio
12.3.5 HAL Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
